Suchergebnisse - "Asano, Yoshimasa"

PubPharm (18)

1

A micro-RNA is the effector gene of a classic evolutionary hotspot locus

enthalten in: bioRxiv : the preprint server for biology | 2024

von Tian, S. | Asano, Y. | Banerjee, T. | +7

2

A micro-RNA is the effector gene of a classic evolutionary hotspot locus

enthalten in: bioRxiv.org | 2024

von Tian, S. | Asano, Y. | Banerjee, T. | +7

3

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

enthalten in: Europäisches Patentamt | 2023

von UI-TEI KUMIKO | KOBAYASHI YOSHIAKI | SAIGO KAORU | +3

4

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

enthalten in: Europäisches Patentamt | 2023

von UI-TEI KUMIKO | KOBAYASHI YOSHIAKI | SATO ATSUSHI | +5

5

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

enthalten in: Europäisches Patentamt | 2023

von UI-TEI KUMIKO | KOBAYASHI YOSHIAKI | SATO ATSUSHI | +5

6

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer : a multicenter phase II clinical trial (PerSeUS-BC04)

enthalten in: Breast cancer (Tokyo, Japan) | 2023

von Futamura, M. | Ishihara, K. | Nagao, Y. | +20

7

SNPD-CRISPR : Single Nucleotide Polymorphism-Distinguishable Repression or Enhancement of a Target Gene Expression by CRISPR System

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2023

von Maruyama, S. | Kusakabe, T. | Zou, X. | +4

8

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)

enthalten in: Breast cancer | 2023

von Futamura, M. | Ishihara, K. | Nagao, Y. | +20

9

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)

enthalten in: Breast cancer | 2023

von Futamura, M. | Ishihara, K. | Nagao, Y. | +20

10

Real time monitoring of cold Ca2+ dependent transcription and its modulation by NCX inhibitors

enthalten in: Scientific reports | 2022

von Wang, H. | Miyairi, S. | Kitamura, M. | +4